Resources
News

James Roosevelt Jr., Longtime Health Care Executive & Prominent Attorney, Joins Verrill Dana

January 17, 2017 Press Releases

(January 17, 2017) – Verrill Dana is pleased to announce that James Roosevelt Jr. has joined the firm's Boston office.

One of the longest serving health care executives in the state, Roosevelt has reentered private practice after more than 10 years as the President and Chief Executive Officer of Tufts Health Plan. Under his leadership, Tufts Health Plan's membership grew significantly, expanded its geographic reach and increased revenues.

Roosevelt brings experience from both the provider and payer perspectives, having chaired the Massachusetts Hospital Association, the Massachusetts Association of Health Plans and America's Health Insurance Plans, and served on the board of the American Hospital Association. He is also a past president of the American Health Lawyers Association.

In 2016, Roosevelt was a distinguished Visiting Fellow at Harvard's Institute of Politics at the John F. Kennedy School of Government. He chairs the Policy and Regulatory Committee of America's Health Insurance Plans. He is a member of the board of directors of Alere Inc. and serves as the chair of its Compensation Committee and member of its Nominating and Governance Committees. He is also a member of the Executive Committee and co-chairs the Rules and By-laws Committee of the Democratic National Committee, as well as volunteering as chief legal counsel of the Massachusetts Democratic Party. In 2008, President-elect Barack Obama appointed Roosevelt to his transition team to co-chair a review of the Social Security Administration. Prior to his role at Tufts Health Plan, he was a partner at a major Boston-based law firm. Roosevelt earned his undergraduate degree from Harvard College and his J.D. from Harvard Law School. He also completed the Advanced Management Program at the Harvard Business School.

"Jim's experience and leadership in the health care industry make him an invaluable addition to our Group and to the firm," said Jeffrey Heidt, Chair of Verrill Dana's Health Care Group. "The health care sector is constantly evolving and shifting, sometimes tumultuously, and Jim has the legal judgment, practical acumen, and big-picture understanding to help our clients make smart adjustments."

Last year, Verrill Dana's Health Care Group welcomed three new attorneys and, with the addition of Roosevelt, has grown 25% since 2015. The Group was also recognized last year by the American Bar Association's Health Law Section, Acquisition International, U.S. News & World Report, and the Chambers & Partners Guide.

Firm Highlights

Publication/Podcast

Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition.

Health care attorney Paul Shaw co-authored Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition with Robert Griffith, published by the American Health Law Association (AHLA). Paul and Robert provide legal...

Publication/Podcast

“If I've told you once, I've told you eight times…” HHS OIG Issues Another Audit Report on Hospitals’ Failure to Report Credits for Explanted Cardiac Devices and Lays the Groundwork Collection of Overpayments

Publication/Podcast

340B Providers Get Partial Relief from New Dispute Resolution Regulation

1. 340B ADR Process Established At long last, more than ten years after Congress directed it to do so, HHS has finalized an alternative dispute resolution (“ADR”) process for both providers and pharmaceutical manufacturers...

Publication/Podcast

The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?

The U.S. Department of Health and Human Services (HHS) completed its “Regulatory Sprint” by finalizing changes to regulations pertaining to two federal fraud and abuse laws. On December 2, 2020, the Centers for Medicare...

Publication/Podcast

HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...

News

Verrill Welcomes Jeffrey A. Smagula, Experienced Health Care and Life Sciences Attorney, Former Health Plan Compliance Executive

(May 12, 2021) – Verrill is pleased to welcome Jeffrey A. Smagula to the firm’s Boston office as Counsel in its nationally recognized Health Care & Life Sciences Group. Jeff Smagula brings to Verrill...

Publication/Podcast

Massachusetts Health Care Bill Makes Several Significant Changes

While you were celebrating the New Year, Governor Baker signed Chapter 260 of the Acts of 2020, an “Act promoting a resilient health care system that puts patients first,” the result of the Legislature’s...

Publication/Podcast

Hospital Price Transparency Rule: Full Steam Ahead

Neither COVID-19 nor continued legal challenges appear likely to derail the Centers for Medicare & Medicaid Services ( CMS) Hospital Price Transparency Rule from going into effect on January 1, 2021. Hospitals therefore should...

News

65 Verrill Attorneys Recognized by Best Lawyers® 2022, Including Eight Named Lawyers of the Year

(August 31, 2021) – 65 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2022 , including 8 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer in...

Contact Verrill at (855) 307 0700